Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00578617 · ClinicalTrials.gov registry record · NA
Ablation vs Drug Therapy for Atrial Fibrillation - Pilot Trial
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT00578617: Completed NA study, sponsored by Mayo Clinic.
NCT00578617 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00578617, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The CABANA pilot study is designed to test the hypothesis that the treatment strategy of percutaneous left atrial catheter ablation for the purpose of the elimination of atrial fibrillation (AF) is superior to current state-of-the-art therapy with either rate control or anti-arrhythmic drugs for reducing AF recurrences at 1 year follow-up.
Interventions
- DRUG Rate Control
- DEVICE Ablation Therapy
- DRUG Rate control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2006-09 |
| Est. Completion | 2010-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00578617
The ClinicalTrials.gov registry entry for NCT00578617 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Rate Control is the first listed.
NCT00578617 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00578617 about?
NCT00578617 is a clinical study titled "Ablation vs Drug Therapy for Atrial Fibrillation - Pilot Trial". The CABANA pilot study is designed to test the hypothesis that the treatment strategy of percutaneous left atrial catheter ablation for the purpose of the elimination of atrial fibrillation (AF) is superior to current state-of-the-art therapy with either rate control or anti-arrhythmic drugs for red...
What is the current status of trial NCT00578617?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2006-09. Estimated completion is 2010-06.
What interventions are being tested in trial NCT00578617?
The interventions under investigation include: Rate Control (DRUG), Ablation Therapy (DEVICE), Rate control (DRUG).
Who is sponsoring clinical trial NCT00578617?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.